Pictet Asset Management Holding Sa Bei Gene, Ltd. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 108,129 shares of BGNE stock, worth $19.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
108,129
Previous 108,831
0.65%
Holding current value
$19.4 Million
Previous $15.5 Million
56.36%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.89 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.15 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$927 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$891 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$664 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $18.6B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...